Randomized, Double-blind, Placebo-controlled, Crossover Trial of the Effect of ACCOLATE on Upper- and Lower-airway Symptoms and Markers of Inflammation Following Exposure to Cat Allergen.

Study identifier:9188US/0019

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Randomized, Double-blind, Placebo-controlled, Crossover Trial of the Effect of ACCOLATE on Upper- and Lower-airway Symptoms and Markers of Inflammation Following Exposure to Cat Allergen.

Medical condition

asthma

Phase

Phase 4

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Interventional

Age

Date

Study Start Date: 01 Jan 1998

Primary Completion Date: -

Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=2058&filename=CSR-9188US-0019.pdf
Download
CSR-9188US-0019.pdf
Download
Trial Results Summaries
Available here

Randomized, Double-blind, Placebo-controlled, Crossover Trial of the Effect of ACCOLATE on Upper- and Lower-airway Symptoms and Markers of Inflammation Following Exposure to Cat Allergen.

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=2058&filename=CSR-9188US-0019.pdf

CSR-9188US-0019.pdf

Trial Results Summaries